Loading data
CLARNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 250.44 m USD | 264.32 m USD | 286.02 m USD | 315.25 m USD | 265.97 m USD |
| Cost of revenue | 167.46 m USD | 171.7 m USD | 188.51 m USD | 205.3 m USD | 178.1 m USD |
| Gross profit | 82.98 m USD | 92.62 m USD | 97.51 m USD | 109.95 m USD | 87.87 m USD |
| Research and development expense | 11.93 m USD | 12.17 m USD | 12.74 m USD | 13.03 m USD | 10.41 m USD |
| Selling, general and administrative expense | 105.17 m USD | 111.95 m USD | 114.6 m USD | 120.81 m USD | 90.66 m USD |
| Operating profit | -59.68 m USD | -70.38 m USD | -21.11 m USD | -106.48 m USD | -12.7 m USD |
| Profit before tax | -57.09 m USD | -70.59 m USD | -20.08 m USD | -107.52 m USD | -17.11 m USD |
| Income tax expense | -10.53 m USD | 17.85 m USD | -4.29 m USD | -14.72 m USD | -19.23 m USD |
| Net income (reported basis) | -46.56 k USD | -88.44 k USD | -15.79 k USD | -69.78 k USD | 26.09 k USD |
| Basic earnings per share | -1.21 USD/share | -1.37 USD/share | -0.27 USD/share | -1.88 USD/share | 0.79 USD/share |
| Diluted earnings per share | -1.21 USD/share | -1.37 USD/share | -0.27 USD/share | -1.88 USD/share | 0.73 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.